Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Some Appreciation for Management

<< Previous

Bullboard Posts

Next >>

Comment by PinnacleXon Jul 20, 2021 12:24pm

115 Views

Post# 33575538

RE:Some Appreciation for Management

Yup, like I just said, didnt take long. Spin it like they do. Credit for what? ITs now worth NOTHING its no longer in the plan(might be in the future, years away, maybe). The only resaon this is still at 4 bucks is now the "hope" of oncology.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing